pharmaphorum53m
FDA starts review of first bronchiectasis drug candidate
The FDA has started a priority review of Insmed's brensocatib, which is pitching to become the first approved therapy for ...
The Pharma Letter44m
X4 Pharma falls as it reveals restructuring program
Shares of rare disease drug developer X4 Pharmaceuticals took a battering after it said it will restructure its workforce and ...
Cosmetics Business22m
L’Oréal 2024 sales rise and heiress Françoise Bettencourt Meyers steps down from board
Dermatological beauty was L’Oréal’s major growth segment for 2024, the French beauty giant reported in its annual results ...